Inhibition of P-glycoprotein by a drug such as quinidine may lead to:
A) Decreased therapeutic levels of quinidine
B) Increased therapeutic levels of quinidine
C) Decreased levels of a coadministered drug, such as digoxin, that requires P-glycoprotein for absorption and elimination
D) Increased levels of a coadministered drug, such as digoxin, that requires P-glycoprotein for absorption and elimination
Correct Answer:
Verified
Q2: Rifampin is a nonspecific CYP450 inducer that
Q3: Genetic polymorphisms account for differences in metabolism,
Q4: Up to 21% of Asians are ultra-rapid
Q5: Carbamazepine has a Black Box Warning recommending
Q6: Pharmacogenetic testing is required by the U.S.
Q7: A provider may consider testing for CYP2D6
Q8: Patients who have a poor metabolism phenotype
Q9: A genetic variation in how the metabolite
Q10: Ultra-rapid metabolizers of drugs may have:
A) To
Q11: Warfarin resistance may be seen in patients
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents